Writing about creatine: is it worth the risk?
Wyss
Markus
M
DSM Nutritional Products, Biotech R & D, Building 203/17B, P.O. Box 3255, CH-4002 Basel, Switzerland. markus.wyss@dsm.com
D002110:Caffeine / Q000494:pharmacology; D000697:Central Nervous System Stimulants / Q000494:pharmacology; D003401:Creatine / Q000009:adverse effects* / Q000627:therapeutic use*; D019587:Dietary Supplements / Q000009:adverse effects; D004340:Drug Contamination; D004734:Energy Metabolism; D005502:Food; D006801:Humans; D015203:Reproducibility of Results; D018570:Risk Assessment; D012449:Safety
D000697:Central Nervous System Stimulants; D002110:Caffeine; D003401:Creatine